mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.08 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.08 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.074 |
0.09 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.09 |